News Industry News Corvia Medical Announces Randomization of First Patient in the RESPONDER-HF Confirmatory Trial December 06, 2022
News Daily News COAPT Risk Score Useful in Predicting Outcomes in Functional MR Michael O'Riordan October 05, 2022
News Conference News TCT 2022 Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year L.A. McKeown September 23, 2022
News Conference News TCT 2022 HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza Todd Neale September 16, 2022
News Features A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts Shelley Wood July 07, 2022
News Daily News Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach Michael O'Riordan June 21, 2022
News Conference News EuroPCR 2022 MitraClip Helps for Atrial Functional MR: MITRA-TUNE Michael O'Riordan May 19, 2022
News Conference News EuroPCR 2022 Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes Caitlin E. Cox May 17, 2022
News Conference News HRS 2022 Intensive BP Control May Stave Off LV Conduction Disease: SPRINT Todd Neale May 02, 2022
News Conference News THT 2022 LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety Caitlin E. Cox February 02, 2022
News Industry News Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients February 02, 2022
News Conference News THT 2022 REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF Shelley Wood February 01, 2022